Dupuytren disease
Paul M.N. Werker
Department of Plastic Surgery, University Medical Centre Groningen, Groningen, The Netherlands
Search for more papers by this authorPaul M.N. Werker
Department of Plastic Surgery, University Medical Centre Groningen, Groningen, The Netherlands
Search for more papers by this authorRoss D. Farhadieh BSc(Med)Hons, MBBS, MD, EBOPRASF, FRACS(Plast), FRCS(Plast)
Panthea Plastic Surgery Clinics, Sydney and Canberra, Australia and Australian National University, Canberra, Australia
Search for more papers by this authorNeil W. Bulstrode BSc(Med)Hons, MBBS, MD, FRCS(Plast)
Clinical Lead Plastic Surgery
Great Ormond Street Hospital, London, UK
Search for more papers by this authorSabrina Cugno MD, MSc, FRCSC
Assistant Professor
McGill University, Department of Plastic Surgery, Montreal Children's Hospital, Montreal, Canada
Search for more papers by this authorSummary
Dupuytren disease is an incurable fibromatosis of the palmar fascia with variable phenotype and disease course. Abnormal fibroblast activity leads to the formation of nodules and myofibroblast activity to the formation of skin pits and cords that may cause flexion contractions. It affects predominantly white males of over 50 years of age and is caused by a combination of genetic and environment causes. Treatment is indicated for painful nodules and progressive finger flexion deformities and can be injection (steroids for nodules; collagenase for cords), radiotherapy (for nodules and very early cords) or surgical (percutaneous or open fasciotomy, limited fasciectomy or dermofasciectomy). Skin defects can be closed by full-thickness skin grafts or left to heal secondarily. The surgical treatment modalities show an inverse relation between degree of invasiveness and durability. This chapter gives an overview of the current knowledge on this subject.
References
- Lanting R, Broekstra DC, Werker PMN, Van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plastic and Reconstructive Surgery 2014; 133(3): 593–603.
- Gudmundsson KG, Jonsson T, Arngrimsson R. Association of morbus Ledderhose with Dupuytren's contracture. Foot & Ankle International 2013; 34(6): 841–845.
- Nugteren HM, Nijman JM, de Jong IJ, van Driel MF. The association between Peyronie's and Dupuytren's disease. International Journal of Impotence Research 2011; 23(4): 142–145.
- Garrod AE. Concerning pads upon the finger joints and their clinical relationships. British Medical Journal 1904; 2(2270): 8.
-
Kuehlein B. The influence of Dupuytren's disease on trigger fingers and vice versa. In: C Eaton, MH Seegenschmiedt, A Bayat, G Gabbiani, PMN Werker, W Wach (eds), Dupuytren's Disease and Related Hyperproliferative Disorders, pp. 249–254. Berlin, Heidelberg: Springer-Verlag; 2012.
10.1007/978-3-642-22697-7_31 Google Scholar
- Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The impact of Dupuytren disease on patient activity and quality of life. Journal of Hand Surgery 2013; 38(6): 1209–1214.
- Hueston JT. Recurrent Dupuytren's contracture. Plastic and Reconstructive Surgery 1963; 31: 66–69.
- Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. Dupuytren's disease on the radial aspect of the hand: report on 135 hands in Japanese patients. Journal of Hand Surgery (British volume) 2004; 29(4): 359–362.
- McGrouther DA. The microanatomy of Dupuytren's contracture. Hand 1982; 14(3): 215–236.
- McFarlane RM. Patterns of the diseased fascia in the fingers in Dupuytren's contracture. Displacement of the neurovascular bundle. Plastic and Reconstructive Surgery 1974; 54(1): 31–44.
- Smith P. Dupuytren's disease. In: Lister's The Hand: Diagnosis and Indication ( 4th edn), p. 527. London: Churchill Livingstone; 2002.
- Skoog T. Dupuytren's contracture: pathogenesis and surgical treatment. Surgical Clinics of North America 1967; 47(2): 433–444.
- McGrouther DA. The palm. In: RM McFarlane, DA McGrouther, MH Flint, eds. Dupuytren's Disease: Biology and Treatment, Vol. 5, The Hand and Upper Limb Series, p. 134. Edinburgh: Churchill Livingstone; 1990.
- Legueu F, Juvara E. Des aponeuroses de la paume de la main. Bullétin de Société anatomique de Paris 1892; 67: 383–400.
- Grapow M. Die Anatomie und Physiologische Bedeutung der Palmaraponeurose. Archiv für Anatomie und Physiologie 1887; 143: 2–3.
- Cleland J. On the cutaneous ligaments of the phalanges. Journal of Anatomy and Physiology 1878; 12: 526.
- Grayson J. The cutaneous ligaments of the digits. Journal of Anatomy 1941; 75(2): 164–165.
- White S. Anatomy of the palmar fascia on the ulnar border of the hand. Journal of Hand Surgery (British volume) 1984; 9B: 51.
- Tubiana R, Simmons BP, DeFrenne HA. Location of Dupuytren's disease on the radial aspect of the hand. Clinical Orthopaedics and Related Research 1982; 168: 222–229.
- Goyrand G. Nouvelles recherches sur la re´traction permanente des doigts. Memoires de l'Academie royale de medecine 1833; 3: 489.
- Iqbal SA, Manning C, Syed F, et al. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy. Stem Cells Development 2012; 21(4): 609–622.
- Hettiaratchy S, Tonkin MA, Edmunds IA. Spiralling of the neurovascular bundle in Dupuytren's disease. Journal of Hand Surgery (European volume) 2010; 35(2): 103–108.
- Brandt KE. An evidence-based approach to Dupuytren's contracture. Plastic and Reconstructive Surgery 2010; 126(6): 2210–2215.
- Tripoli M, Cordova A, Moschella F. Dupuytren's contracture as result of prolonged administration of phenobarbital. European Review for Medical and Pharmacological Sciences 2011; 15(3): 299–302.
- Descatha A, Jauffret P, Chastang JF, Roquelaure Y, Leclerc A. Should we consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate. BMC Musculoskeletal Disorders 2011; 12: 96.
- Dolmans GH, Werker PM, Hennies HC, et al. Wnt Signaling and Dupuytren's disease. New England Journal of Medicine 2011; 365: 307–317.
- Dolmans GH, de Bock GH, Werker PM. Dupuytren diathesis and genetic risk. Journal of Hand Surgery 2012; 37(10): 2106–2111.
- Capstick R, Bragg T, Giele H, Furniss D. Sibling recurrence risk in Dupuytren's disease. Journal of Hand Surgery (European volume) 2013; 38(4): 424–429.
- Gabbiani G, Majno G. Dupuytren's contracture: fibroblast contraction? An ultrastructural study. American Journal of Pathology 1972; 66(1): 131–146.
- Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Reviews Molecular Cell Biology 2002 May; 3(5): 349–363.
- Verhoekx JS, Beckett KS, Bisson MA, McGrouther DA, Grobbelaar AO, Mudera V. The mechanical environment in Dupuytren's contracture determines cell contractility and associated MMP-mediated matrix remodeling. Journal of Orthopedic Research 2013; 31(2): 328–334.
- Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biology Reports 2010; 2: 78.
- Luck JV. Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. Journal of Bone and Joint Surgery (American volume) 1959; 41-A(4): 635–664.
- 31.Lam WL, Rawlins JM, Karoo RO, Naylor I, Sharpe DT. Re-visiting Luck's classification: a histological analysis of Dupuytren's disease. Journal of Hand Surgery (European volume) 2010; 35(4): 312–317.
- Rayan GM. Clinical presentation and types of Dupuytren's disease. Hand Clinics 1999; 15(1): 87–96, vii.
- Ragois P, Didailler P, Rizzi P. Skin metastasis of lung carcinoma like Dupuytren's disease. Chirurgie de la Main 2012; 31(5): 259–261.
- Iselin M. The forms of Dupuytren's disease. Concours Medical 1955; 77(51): 4769–4771.
- Tubiana R, Michon J, Thomine JM. Scheme for the assessment of deformities in Dupuytren's disease. Surgical Clinics of North America 1968; 48(5): 979–984.
- Tubiana R. Evaluation of deformities in Dupuytren's disease. Annales de Chirurgie de la Main 1986; 5(1): 5–11.
- Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskeletal Disorders 2013; 14: 131–247.
- Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease – a systematic review. Journal of Hand Surgery (European volume) 2010; 35(8): 623–626.
- Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. Journal of Hand Surgery 2000; 25(6): 1157–1162.
- Denkler K. Collagenase for recurrent Dupuytren contracture with skin grafts. Journal of Hand Surgery 2013; 38(6): 1264.
- Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. New England Journal of Medicine 2009; 361(10): 968–979.
- Gordon S. Dupuytren's Contracture. Canadian Medical Association Journal 1948; 58: 543–547.
- Keilholz L, Seegenschmiedt MH, Sauer R. Radiotherapy for prevention of disease progression in early-stage Dupuytren's contracture: initial and long-term results. International Journal of Radiation Oncology Biology Physics 1996; 36(4): 891–897.
- Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R, Keilholz L. Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years. Strahlentherapie und Onkologie 2010; 186(2): 82–90.
- Dahlin LB, Bainbridge C, Szczypa PP, Cappelleri JC, Guerin D, Gerber RA. Current trends in the surgical management of Dupuytren's disease in Europe: the surgeon's perspective. European Orthopaedics and Traumatology 2012; 3(1): 25–30.
- Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. Journal of Hand Surgery 2007; 32(2): 240–245.
- Donaldson OW, Pearson D, Reynolds R, Bhatia RK. The association between intraoperative correction of Dupuytren's disease and residual postoperative contracture. Journal of Hand Surgery (European volume) 2010; 35(3): 220–223.
- Moermans JP. Segmental aponeurectomy in Dupuytren's disease. Journal of Hand Surgery (British volume) 1991; 16(3): 243–254.
- Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. Journal of Hand Surgery (British volume) 1996; 21(6): 797–800.
- Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren's disease with metacarpophalangeal flexion contracture. Journal of Hand Surgery (British volume) 2001; 26(4): 360–361.
- Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren's disease. Journal of Bone and Joint Surgery (British volume) 2000; 82(1): 90–94.
- Elliot D. The early history of contracture of the palmar fascia. Part 1: The origin of the disease: the curse of the MacCrimmons: the hand of benediction: Cline's contracture. Journal of Hand Surgery (British volume) 1988; 13(3): 246–253.
- Stewart C, Davidson D, Hooper G. Re-operation after open fasciotomy for Dupuytren's disease in a series of 1077 consecutive operations. Journal of Hand Surgery (European volume) 2013; 39(5): 553–554.
- Eaton C. Percutaneous fasciotomy for Dupuytren's contracture. Journal of Hand Surgery 2011; 36(5): 910–915.
- McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study. Journal of Hand Surgery 2012; 37(7): 1307–1312.
- Broekstra DC, Werker PM. Steroid injections in combination with needle aponeurotomy as a treatment method for Dupuytren disease: suggestions for increasing the research evidence. Journal of Hand Surgery 2012; 37(11): 2429–2430; author reply 2430–2431.
- Tonkin MA, Burke FD, Varian JP. The proximal interphalangeal joint in Dupuytren's disease. Journal of Hand Surgery (British volume) 1985; 10(3): 358–364.
- Crowley B, Tonkin MA. The proximal interphalangeal joint in Dupuytren's disease. Hand Clinics 1999; 15(1): 137–147, viii.
- Breed CM, Smith PJ. A comparison of methods of treatment of pip joint contractures in Dupuytren's disease. Journal of Hand Surgery (British volume) 1996; 21(2): 246–251.
- Smith P, Breed C. Central slip attenuation in Dupuytren's contracture: a cause of persistent flexion of the proximal interphalangeal joint. Journal of Hand Surgery 1994; 19(5): 840–843.
- Citron N, Messina JC. The use of skeletal traction in the treatment of severe primary Dupuytren's disease. Journal of Bone and Joint Surgery (British volume) 1998; 80(1): 126–129.
- Messina A, Messina J. The continuous elongation treatment by the TEC device for severe Dupuytren's contracture of the fingers. Plastic and Reconstructive Surgery 1993; 92(1): 84–90.
- Craft RO, Smith AA, Coakley B, Casey WJ, III, Rebecca AM, Duncan SF. Preliminary soft-tissue distraction vs checkrein ligament release after fasciectomy in the treatment of Dupuytren PIP joint contractures. Plastic and Reconstructive Surgery 2011 128(5): 1105–1113.
- McCash CR. The open palm technique in Dupuytren's contracture. British Journal of Plastic Surgery 1964; 17: 271–280.
- Ketchum LD. The use of the full thickness skin graft in Dupuytren's contracture. Hand Clinics 1991; 7(4): 731–741; discussion 743.
- Jacobsen K, Holst-Nielsen F. A modified McCash operation for Dupuytren's contracture. Scandinavian Journal of Plastic and Reconstructive Surgery 1977; 11(3): 231–233.
- Kan HJ, Hovius SE. Long-term follow-up of flaps for extensive Dupuytren's and Ledderhose disease in one family. Journal of Plastic, Reconstructive & Aesthetic Surgery 2012; 65(12): 1741–1745.
- van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. Journal of Hand Surgery 2006; 31(5): 717–725.
- Barton NJ. Dupuytren's disease arising from the abductor digiti minimi. Journal of Hand Surgery (British volume) 1984; 9(3): 265–270.
- Denkler K. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. Eplasty 2010; 10: e15.
- McFarlane RM, McGrouther DA. Complications and their management. In: RM McFarlane, DA McGrouther, MH Flint (eds), Dupuytren's Disease: Biology and Treatment, pp. 377–382. Edinburgh: Churchill Livingstone; 1990.
- Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy]. Revue de rhumatisme Société française de rhumatologie 1993; 60(11): 808–813.
- Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. Journal of Hand Surgery 2012; 37(4): 651–656.
- Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. Journal of Hand Surgery 2012; 37(10): 2095–2105, e7.
- Leclercq C, Tubiana R. [Long-term results of aponeurectomy for Dupuytren's disease]. Chirurgie 1986; 112(3): 194–197.
- van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plastic and Reconstructive Surgery 2012; 129(2): 469–477.
- Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. Journal of Hand Surgery 2013; 38(1): 12–22.
- Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. Journal of Hand Surgery 2010; 35(4): 534–9, e1.
-
Seegenschmiedt MH. Long term outcome of radiotherapy for early stage Dupuytren's disease: a phase III clinical study. In: C Eaton, MH Seegenschmiedt, A Bayat, G Gabbiani, PMN Werker, W Wach (ed.), Dupuytren's Disease and Related Hyperproliferative Disorders, pp. 349–372. Berlin, Heidelberg: Springer Verlag; 2012.
10.1007/978-3-642-22697-7_44 Google Scholar
- Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. Journal of Hand Surgery (British volume) 2006; 31(5): 514–521.
- Jurisic D, Kovic I, Lulic I, Stanec Z, Kapovic M, Uravic M. Dupuytren's disease characteristics in Primorsko-goranska County, Croatia. Collegium Antropologicum 2008; 32(4): 1209–1213.
- Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren's contracture. Journal of Hand Surgery 1987; 12(5 Part 1): 659–664.
- Ullah AS, Dias JJ, Bhowal B. Does a ‘firebreak’ full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. Journal of Bone and Joint Surgery (British volume) 2009; 91(3): 374–378.
- Van Giffen N, Degreef I, De Smet L. Dupuytren's disease: outcome of the proximal interphalangeal joint in isolated fifth ray involvement. Acta Orthopedica Belgica 2006; 72(6): 671–677.
- Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. Journal of Hand Surgery (British volume) 2003; 28(5): 427–431.
- Hovius SE, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plastic and Reconstructive Surgery 2011; 128(1): 221–228.
- Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia. Journal of Surgical Research 2002; 103(2): 146–152.
- Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Chirurgie de la Main 2000; 19(1): 15–22.
- Bulstrode NW, Bisson M, Jemec B, Pratt AL, McGrouther DA, Grobbelaar AO. A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of Dupuytren's disease. Journal of Hand Surgery (British volume) 2004; 29(1): 18–21.
-
Degreef I, Tejpar S, De Smet L. Highly dosed Tamoxifen in Therapy-Resisting Dupuytren's Disease. In: C Eaton, MH Seegenschmiedt, A Bayat, G Gabbiani, PMN Werker, W Wach (eds), Dupuytren's Disease and Related Hyperproliferative Disorders, pp. 379–386. Heidelberg: Springer; 2012.
10.1007/978-3-642-22697-7_46 Google Scholar
- Degreef I, Tejpar S, De Smet L. Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implant. Journal of Plastic Surgery and Hand Surgery 2011; 45(3): 157–164.
- Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Annals of Plastic Surgery 2006; 57(1): 13–17.
- Bainbridge C, Gerber RA, Szczypa PP, Smith T, Kushner H, Cohen B, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. Journal of Plastic Surgery and Hand Surgery 2012; 46(3–4): 177–183.
- Hay DC, Louie DL, Earp BE, Kaplan FT, Akelman E, Blazar PE. Surgical findings in the treatment of Dupuytren's disease after initial treatment with clostridial collagenase (Xiaflex). Journal of Hand Surgery (European volume) 2013; 39(5): 463–465.
- Larson D, Jerosch-Herold C. Clinical effectiveness of post-operative splinting after surgical release of Dupuytren's contracture: a systematic review. BMC Musculoskeletal Disorders 2008; 9: 104.
- Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disorders 2011; 12(1): 136.
- Collis J, Collocott S, Hing W, Kelly E. The effect of night extension orthoses following surgical release of Dupuytren contracture: a single-center, randomized, controlled trial. Journal of Hand Surgery 2013; 38(7): 1285–1294, e2.
- Kemler MA, Houpt P, van der Horst CM. A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy for Dupuytren's disease. Journal of Hand Surgery (European volume) 2012; 37(8): 733–737.
- Herweijer H, Dijkstra PU, Nicolai JP, Van der Sluis CK. Postoperative hand therapy in Dupuytren's disease. Disability and Rehabilitation 2007; 29(22): 1736–1741.
- van Rijssen AL, Werker PM. Percutaneous needle fasciotomy for recurrent Dupuytren disease. Journal of Hand Surgery 2012; 37(9): 1820–1823.
- Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau TR. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. Journal of Hand Surgery 2013; 38(1): 2–11.
- Chen NC, Srinivasan RC, Shauver MJ, Chung KC. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (New York) 2011; 6(3): 250–255.